• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 59
  • 44
  • 25
  • 9
  • 4
  • 3
  • 1
  • Tagged with
  • 159
  • 55
  • 48
  • 36
  • 35
  • 33
  • 30
  • 28
  • 20
  • 20
  • 20
  • 18
  • 18
  • 16
  • 16
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
101

Etude de l’interaction de Mycoplasma hominis PG21 avec les cellules dendritiques humaines. : Caractérisation de la fraction bioactive du mycoplasme et réponse immunitaire innée de la cellule / Interaction of Mycoplasma hominis PG21 with human dendritic cells : bioactive fraction of the mycoplasma and innate immune response of the cells

Goret, Julien 07 December 2015 (has links)
Mycoplasma hominis est une bactérie opportuniste qui peut être responsable d’infections du tractus urogénital, d’infections néonatales ou d’infections disséminées notamment chez les patients immunodéprimés. La membrane des mycoplasmes constitue l’interface d’interaction directe avec le milieu extérieur en raison de l’absence de paroi. Cette membrane contient de nombreuses lipoprotéines qui ont le pouvoir d’activer des cellules dendritiques humaines (hDCs), d’induire la production de cytokines et de polariser le système immunitaire adaptatif. Nous avons étudié l’interaction de M. hominis PG21 avec les hDCs en nous penchant d’une part sur la fraction du mycoplasme qui active les hDCs et d’autre part sur la réponse immunitaire innée des hDCs. Apres avoir déterminé les lipoprotéines contenues dans un extrait TX-114 de M. hominis PG21, nous avons enrichi en lipoprotéines bioactives une fraction de vésicules membranaires du mycoplasme par une double extraction utilisant deux détergents non dénaturants, le Sarkosyl puis le Triton X-114. Apres séparation par SDS-PAGE, nous avons identifié vingt lipoprotéines qui pourraient entrainer la sécrétion d’IL-23 par les hDCs, notamment la lipoprotéine MHO_4720. Un lipopeptide synthétique correspondant à la fraction N-terminale de MHO_4720 est capable de stimuler les hDCs. En analysant les variations transcriptionnelles des gènes codant pour les 48 lipoprotéines de M. hominis PG21 par qRT-PCR, nous avons également déterminé que 21 lipoprotéines sont surexprimées après 4h ou 24h de contact entre le mycoplasme et les hDCs. Enfin, la réponse cellulaire a été évaluée par PCR array et ELISA. Nous avons observé l’activation d’inflammasome(s) par la mise en évidence de la production d’IL-1β dépendant de la caspase 5. / Mycoplasma hominis is involved in urogenital tract infections, neonatal infections or disseminated infections particularly in immunocompromised patients. Mycoplasmas have no cell wall and their membrane is the main interface mediating the interaction between the mycoplasma and its environment. Lipoproteins that are anchored to the extracellular side of the plasma membrane are known to induce the maturation of human dendritic cells (hDCs), to stimulate the pro-inflammatory cytokine production by hDCs and to polarize the adaptive immune system. We studied the interaction of M. hominis PG21 with hDCs in order to assess the lipoproteins that can induce the stimulation of hDCs, to determine the lipoproteins that are regulated upon interaction of the mycoplasma with the host cell and to evaluate the innate host cell response. Using a double extraction strategy with two non-denaturing detergents, Sarkosyl then Triton X-114, and separation by SDS-PAGE, we found that 20 lipoproteins may induce the secretion of IL-23 by the hDCs, especially the MHO_4720 lipoprotein. We showed that a synthetic lipopeptide corresponding to the N-terminus part of the MHO_4720 lipoprotein can stimulate the hDCs in a dose-dependent manner. Using qRT-PCR for the evaluation of the transcriptional regulation of the 48 lipoprotein-coding genes of M. hominis PG21, we also determined that 21 lipoproteins were upregulated upon 4h and 24h of contact of M. hominis with hDCs. Finally, the hDC innate immune response was evaluated by PCR array and ELISA. We observed a caspase 5-dependent production of IL- 1β corresponding to the activation of an inflammasome.
102

Étude du rôle de l’inflammasome et de la kinase Styk1 dans la régulation des lymphocytes cytotoxiques / Role of the inflammasome and of Styk1 kinase in the regulation of cytotoxic lymphocytes

Fauteux-Daniel, Sébastien 27 March 2018 (has links)
Le dysfonctionnement de l'exocytose des granules cytotoxiques est responsable d'une susceptibilité accrue aux pathogènes intracellulaires qui s'accompagne de l'activation continue et anarchique des lymphocytes cytotoxiques et des macrophages. Ce phénomène conduit à la lymphohistiocytose hémophagocytique (HLH), un syndrome auto-inflammatoire fatal en absence d'intervention thérapeutique. Les mutations des gènes codant pour la perforine (PRF-1) ou pour certaines des protéines impliquées dans la biogénèse ou le transport vésiculaire des granules cytotoxiques sont causales des formes familiales ou primaires de la HLH (FHL). La HLH fait également partie des complications secondaires aux infections à herpesviridae et à certains désordres immunologiques importants tels que l'arthrite juvénile idiopathique (SoJIA). Au moment d'entreprendre les travaux présentés dans ce manuscrit, le premier cas de HLH induite par une mutation menant à l'activation constitutive de la composante NLRC4 de l'inflammasome était décrit. L'inflammasome est une structure multimérique composée d'un récepteur cytosolique, de la protéine échafaud ASC et de la Caspase-1. Son activation mène à la maturation des pro-formes de l'IL-1β et l'IL-18 ainsi qu'à leur sécrétion. L'activation constitutive de NLRC4 étant suffisante au déclenchement de la HLH, nous avons tenté de comprendre si cette structure y était essentielle dans le cadre des défauts génétiques de cytotoxicité. Nous avons donc invalidé la protéine ASC ou Caspase-1 dans le modèle murin de HLH déficient pour la perforine (PRF1 -/-). Nous avons également testé l'hypothèse qu'un déficit de cytotoxicité pouvait expliquer le développement de la HLH chez les patients souffrant de SoJIA. Nos résultats montrent que l'inflammasome est nécessaire à la production d'IL-18 lors de la HLH mais qu'il n'est pas essentiel au développement de la maladie dans le cadre des FHL. Par ailleurs, nous montrons que la cytotoxicité des cellules NK semble normale chez les patients atteints de SoJIA, ce qui suggère que les mécanismes immunologiques à l'origine de la HLH dans les FHL et dans les maladies autoinflammatoires comme la SoJIA sont distincts. Dans la seconde partie de ce manuscrit, nous avons étudié sur le rôle de la sérine/thréonine/tyrosine kinase Styk1 dans la régulation des lymphocytes cytotoxiques NK. Ces derniers sont responsables du contrôle immunitaire précoce des pathogènes intracellulaires et contribuent à l'immunosurveillance des cellules tumorales. Suite à leur activation, ils relâchent de très grandes quantités d'IFN-y et de TNF-α, faisant ainsi le lien entre l'immunité innée et adaptative. La reconnaissance des cellules cibles par les lymphocytes NK est gouvernée par l'expression d'un éventail de récepteurs qui transduisent des signaux, activateurs ou inhibiteurs, et dont la balance se traduit par l'activation ou la tolérance. Ces récepteurs sont codés au sein de deux complexes génétiques très denses, le complexe de cytotoxicité naturelle (NCR) et le complexe des récepteurs des leucocytes (LRC). Au moment de commencer ces travaux, nous avions révélé que l'expression de la kinase Styk1 fait partie de la signature transcriptionnelle des lymphocytes NK. Sa fonction dans le système immunitaire demeure toutefois inconnue. Néanmoins, la localisation génétique favorable de Styk1, près du NCR, ainsi que son implication dans la voie PI3K-AKT, en faisaient un candidat potentiel de régulation des lymphocytes NK. Afin de connaître le rôle de Styk1 dans le développement et les fonctions effectrices des lymphocytes NK, nous avons donc généré une souris pour laquelle Styk1 est invalidé. Nos résultats confirment que Styk1 est exprimée de façon spécifique par les cellules NK. Nous avons également détecté une diminution de l'activité constitutive de la voie AKT/mTOR dans les cellules NK, mais le développement, l'homéostasie et la fonction des cellules NK sont cependant normaux dans les souris déficientes en Styk1 / Upon recognition of infected or target cells, CD8+ T and Natural Killer (NK) lymphocytes initiate a polarized degranulation of vesicle storing cytotoxic molecules (perforin: PRF1 and granzyme B). By altering the target cell’s cellular membrane integrity, perforine allows granzyme B to translocate to its cytosol. Genetic anomalies may affect normal cytotoxic functions and severely hamper the control of intracellular pathogens. In this context, the pathogenic signal remains uninterrupted and both cytotoxic lymphocytes and macrophages are continuously stimulated. This auto-inflammatory pathological condition is named hemophagocytic lymphohistiocytosis (HLH) and is fatal without therapeutic intervention. HLH can also occur secondary to infection with viruses from the herpesviridae family, or be concomitant to important immune alterations such as systemic onset juvenile idiopathic arthritis (SoJIA), with no clear etiological cause identified. In 2014, a case of HLH mediated by the constitutive activation of the NLRC4 inflammasome receptor was first described. The inflammasome is a multimeric structure involving a cytosolic receptor, a scaffold protein – ASC – and Caspase-1. In the immune system, the inflammasome is expressed in macrophages and dendritic cells and senses pathogenic (PAMP) and danger (DAMP) associated signals. Once activated, inflammasome’s protein Caspase-1 catalyzes the maturation of pro-IL-1b and pro-IL-18 and leads to their secretion. Since NLRC4 constitutive activation appears to be sufficient for triggering HLH, we aimed to understand if the inflammasome structure was essential to the development of the syndrome. In order to address this question, we invalidated the inflammasome through the abrogation of ASC or Caspase-1 in PRF1 -/- HLH mouse model. We also tested the hypothesis that an altered cytotoxic function could explain the high prevalence of HLH in the proinflammatory context of SoJIA. The results we present here show that the inflammasome is responsible for the elevated levels of IL-18 in the serum of HLH patients. However, the inflammasome is facultative for its development. We also demonstrate that in patients suffering from SoJIA, NK cells show normal cytotoxicity, suggesting that immunological mechanisms involved in FHL and secondary HLH are distinct. In the second part of this manuscript, we aim at understanding the role of Styk1 serine/threonine/tyrosine kinase in NK cells’ regulation. NK cells are in charge of eliminating stressed, virally infected or transformed cells. Upon activation, they secrete large amounts of IFN-γ and TNF-α, thus bridging innate and adaptive immunity. Capabilities for recognition of target cells is endowed by the expression of numerous stochastically expressed activating and inhibitory receptors. The balance between activating and inhibitory signal allows for self-tolerance or activation upon engagement of abnormal cells. Activating and inhibitory receptor are germline encoded in two dense, large complexes, the Natural Killer Complex (NKC) and the Leukocyte Receptor Complex (LRC). At the moment of starting this work, we had recently identified that Styk1 was a signature transcript of NK cells. However, its function in NK cells and more generally in the immune system remains unknown. Nevertheless, its genetic localisation near the NKC and its potential implication in the PI3K-AKT pathway prompt that it may play a role in NK cell development and/or functions. In order to evaluate the role of Styk1 in NK cells’ regulation, we generated a mouse model in which its expression is abrogated. Our data confirms that amongst all immune subsets, Styk1 is specifically expressed by NK cells. Styk1 was also able to discriminate NK cells from other ILCs. In this study, we show that Styk1 invalidation lead to a decrease of activity in the AKT/mTOR pathway. However, NK cells development, homeostasis and function were surprisingly normal in Styk1 -/- mice
103

Immunogénicite de la mort cellulaire induite par les chimiothérapies anti-cancéreuses

Aymeric, Laetitia 16 June 2011 (has links) (PDF)
Le développement d'un cancer chez un individu immunocompétent témoigne del'inefficacité de ses défenses immunitaires naturelles à entraver la progression tumorale. Larestauration ou l'induction de réponses immunitaires anti-tumorales efficaces sont des enjeuxmajeurs des stratégies thérapeutiques actuelles. En plus des immunothérapies classiques,visant à activer le système immunitaire des patients contre leurs tumeurs, les thérapiesconventionnelles, telles que les chimiothérapies et la radiothérapie, peuvent avoir des effetsimmunostimulants, en parallèle de leur effet directement cytotoxique sur les cellulestumorales. Parmi celles-ci, les anthracyclines, l'oxaliplatine et la radiothérapie sontnotamment capables d'induire une mort cellulaire immunogène. L'efficacité thérapeutique deces traitements dépend de l'activation de lymphocytes T (LT) CD8 anti-tumoraux,producteurs d'interféron-gamma (IFN-γ). En utilisant des modèles murins de tumeurstransplantées, nous montrons que le traitement des cellules tumorales par des droguesimmunogènes induit la libération d'adénosine triphosphate (ATP) dans le milieu extracellulaire.Ce signal de danger endogène se lie à son récepteur P2RX7 sur les cellulesdendritiques et permet la formation de l'inflammasome NLRP3/ASC/pro-caspase 1,conduisant à l'activation protéolytique de la caspase 1, qui active la pro-interleukine-1β (pro-IL-1β) en interleukine-1β (IL-1β). L'IL-1β peut directement agir sur les LT CD8 pourfaciliter leur polarisation vers un phénotype de lymphocytes T cytotoxiques de type 1 (Tc1).De plus, le traitement de tumeurs établies par des drogues immunogènes induit uneproduction d'IL-17A (IL-17) dans le lit tumoral, au cours de la première semaine suivant letraitement. Les LT gamma delta (LTγδ) sont les principaux producteurs de cette cytokinedans nos modèles. Ces cellules s'accumulent transitoirement dans la tumeur dès le troisièmejour suivant le traitement et leur taux est parfaitement corrélé à celui des LT CD8 producteursd'IFN-γ tumoraux. Comme l'IFN-γ, l'IL-17 et les LTγδ sont nécessaires à l'efficacitéthérapeutique des drogues immunogènes. L'IL-1β produite par les cellules dendritiquesexposées à des corps apoptotiques immunogènes stimule directement la production d'IL-17par les LTγδ. Ces travaux ont contribué à identifier l'ATP extra-cellulaire comme undéterminant moléculaire de l'immunogénicité des cellules tumorales exposées à certainesthérapies anti-cancéreuses conventionnelles. De plus, nous montrons que les traitementscytotoxiques classiques peuvent moduler l'environnement immunitaire dans le lit tumoral, etcontribuer à remplacer une inflammation chronique et immunosuppressive en uneinflammation aigüe et immunogène. L'étude des interactions entre le système immunitaire etles thérapies anti-cancéreuses conventionnelles est nécessaire pour utiliser ces traitements demanière plus rationnelle, en les combinant par exemple à des immunothérapies plusclassiques.
104

Role of Vav2 in Podocyte Inflammasome Activation and Glomerular Injury During Hyperhomocysteinemia

Conley, Sabena 01 January 2016 (has links)
Hyperhomocysteinemia (hHcys) is a widely known pathogenic factor in the progression of end-stage renal disease (ESRD) and it is also associated with an increased risk for injurious cardiovascular pathologies during ESRD. HHcys is linked to the formation and activation of the NOD-like receptor protein 3 (NLRP3) inflammasome, characterized as a critical early mechanism initiating the inflammatory response. NADPH oxidase (NOX)-derived reactive oxygen species (ROS) mediate the activation of the NLRP3 inflammasome in podocytes in response to elevated levels of homocysteine (Hcys) in vitro and in vivo. However, it remains unknown how NLRP3 inflammasome activation is triggered by NOX. The aim of the present study sought to determine the signaling cascade that triggers glomerular injury and sclerosis during hHcys mediated by Vav2, a guanine nucleotide exchange factor (GNEF). Using both genetic and pharmacological interventions of Vav2, we first tested whether this GNEF is involved in hHcys-induced NLRP3 inflammasome activation in podocytes by its role in activation of the Rac-1-NOX complex. Further, we explored whether pharmacological targeting of Vav2 activation may regulate NLRP3 inflammasome signaling pathway during hHcys-induced glomerular injury. We found that mice with hHcys (on the FF diet) or oncoVav2 (a constitutively active form of Vav2) transfection in the kidney exhibited increased colocalization of NLRP3 with apoptosis-associated speck-like protein (ASC) or caspase-1 and elevated IL-1β levels in glomeruli, indicating the formation and activation of the NLRP3 inflammasome. This glomerular NLRP3 inflammasome activation was accompanied by podocyte dysfunction and glomerular injury, even sclerosis. Local transfection of Vav2 shRNA plasmids significantly attenuated hHcys-induced NLRP3 inflammasome activation, podocyte injury, and glomerular sclerosis. In cultured podocytes, Hcys treatment and oncoVav2 transfection increased NLRP3 inflammasome formation and activation. This NLRP3 activation was inhibited by Vav2 shRNA, associated with reduction of Rac-1 activity and ROS production. Administration of NSC23766, a Rac-1 inhibitor substantially attenuated inflammasome formation, desmin expression and decreased podocin expression in glomeruli of hHcys mice. These results suggest that elevated Hcys levels activate Vav2 and thereby increase NOX activity, leading to ROS production. ROS trigger NLRP3 inflammasome activation, podocyte dysfunction and glomerular injury. Therefore, the present study defines a novel mechanism underlying hHcys-induced NLRP3 inflammasome activation and its progression to ESRD.
105

Participação de diferentes subtipos de macrófagos e a contribuição do ácido úrico solúvel, dos receptores TLR2 e TLR4 e das moléculas MyD88 e NLRP3 para o desenvolvimento da fibrose renal. / Involvement of different subtypes of macrophages and the contribution of soluble uric acid, the receptors TLR2 and TLR4 and MyD88 and NLRP3 molecules to the development of renal fibrosis.

Braga, Tárcio Teodoro 16 June 2014 (has links)
A doença renal crônica é uma doença mediada pelo sistema imune e caracterizada por fibrose. Camundongos deficientes em TLR2, TLR4, MyD88 e NLRP3 se mostraram protegidos frente ao dano renal e à deposição de colágeno após serem submetidos à obstrução unilateral do ureter (UUO). Além disso, os camundongos protegidos exibiram menor produção de citocinas relacionadas com um perfil imune Th2 e apresentaram menor acúmulo de macrófagos do subtipo M2. Inicialmente, creditamos aos macrófagos M2 o papel de macrófagos formadores de fibrose uma vez que tal subpopulação é encontrada em maior número aos sete dias após a UUO em animais WT, porém, vimos que os personagens centrais no desenvolvimento da fibrose são macrófagos M1, encontrados no início da lesão renal. Também vimos que o ácido úrico é a molécula capaz de induzir a troca de fenótipo de M1 para M2 ao longo da UUO, além de ser capaz de ativar a via do inflamassoma. O ácido úrico solúvel é liberado em um contexto de hipóxia e ativa o complexo do inflamassoma NLRP3 por mecanismos diferentes, mas complementares. / Chronic kidney disease is an immune mediated disease characterized by fibrosis development. The damaged tissue releases molecules such as soluble uric acid resulting from the degradation of extracellular matrix or dead cells, which activate TLR and NLR, leading to the translocation of MyD88 in many cell types. This modulation of the immune system interferes with the activation of different subtypes of macrophages and activity of CD4+ T cells, with the Th1/Th2 paradigm as a possible effector mechanism of fibrosis. TLR2, TLR4, MyD88, and NLRP3 deficient mice are protected against renal damage and collagen deposition after being submitted to unilateral ureteral obstruction (UUO), when compared to wild type animals. Moreover, protected mice exhibited less production of Th2 related cytokines and reduced accumulation of M2 macrophages. Initially, we hypothesized M2 macrophages are responsible for fibrosis formation since this subset is found in greater numbers seven days after UUO in WT mice, however, we observed the central characters on the development of fibrosis are M1 macrophages found in the onset of renal injury. These data were confirmed by the injection of Stat6 KO M1 macrophages into Rag deficient mice previously depleted of macrophages and subjected to UUO, in which we observed higher proteinuria and increased collagen deposition. We also observed that uric acid is able to induce the exchange of phenotype from M1 to M2 along the UUO, besides being able to activate the inflammasome pathway. The soluble uric acid is released in the context of hypoxia and activates the NLRP3 inflammasome complex by different, but complementary mechanisms. Therefore, the renal damage releases soluble uric acid, which signals via innate immune receptors, and the damage brings as a consequence the deposition of proteins in the renal interstitium, culminating in fibrosis.
106

Papel do inflamassoma NLRP3 nas alterações vasculares promovidas pelo diabetes tipo 1 em modelo induzido por estreptozotocina / Role of the NLRP3 inflammasome in the vascular alterations induced by type 1 diabetes in a streptozotocin-induced model

Pereira, Camila André 10 August 2018 (has links)
O diabetes mellitus (DM) está associado a diversas complicações micro e macrovasculares diretamente relacionadas a doenças cardiovasculares. A prolongada exposição à hiperglicemia e a resistência a insulina são considerados os principais fatores envolvidos nestas complicações, as quais são exacerbadas pela disfunção endotelial. Mediadores inflamatórios contribuem potencialmente para o desenvolvimento de disfunção endotelial pela geração de espécies reativas de oxigênio (EROs) que, por sua vez, estimulam a transcrição de fatores pró- inflamatórios. Receptores específicos, como os NLRs (NOD-like receptors, receptores do tipo NOD) contribuem para instalação de processo inflamatório pela ativação do complexo inflamassoma. Este regula a ativação da caspase-1 e o processamento proteolítico dos precursores pró-IL-1? e pró-IL-18 nas citocinas maduras. Diversos mediadores podem ativar o inflamassoma NLRP3 como, por exemplo, EROs e DNA mitocondrial. Pouco é conhecido sobre o envolvimento de receptores NLRP3 e DNA mitocondrial na disfunção endotelial associada ao diabetes. Testamos a hipótese que a deficiência genética do receptor NLRP3 confere resistência à ativação de processo inflamatório na vasculatura de animais com diabetes tipo 1 (DM1) e, ainda, que DNA mitocondrial contribui para a ativação vascular do inflamassoma NLRP3 e para disfunção endotelial. Foram utilizados camundongos C57Bl/6 e deficientes para NLRP3, os quais foram tratados com veículo ou submetidos a protocolo para indução de DM1 com estreptozotocina. Parâmetros vasculares funcionais foram determinados em artérias mesentéricas de resistência. Células de músculo liso vascular (CMLV) e endoteliais foram utilizadas para avaliação da ativação do inflamassoma NLRP3 por DNA mitocondrial. A geração de EROs foi avaliada pela fluorescência para o dihidroetídio e pela quimiluminescência para lucigenina. A ativação de caspase-1 e IL-1? foi avaliada por western blot e o influxo de cálcio, por fluorescência. DNA mitocondrial foi avaliado pela expressão gênica de componentes da mitocôndria. O diabetes reduziu a vasodilatação dependente de endotélio, o que não ocorreu em artérias de animais deficientes de NLRP3. Animais diabéticos apresentaram aumento da expressão vascular do receptor NLRP3, da ativação de caspase-1 eIL-1? e da geração de EROs e peróxido de hidrogênio no leito mesentérico, eventos que ocorreram em menor intensidade em camundongos deficientes de NLRP3. Houve redução na expressão proteica vascular de Nox4 (NADPH oxidase 4), bem como na expressão gênica da molécula de adesão celular vascular-1 (VCAM-1, vascular cell adhesion molecule-1) e molécula de adesão intercelular-1 (ICAM-1, intercellular adhesion molecule-1) em animais deficientes de NLRP3. Houve aumento da liberação de DNA mitocondrial citosólico no pâncreas de animais diabéticos. A incubação com o DNA mitocondrial extraído do pâncreas de animais diabéticos promoveu ativação do inflamassoma em CMLV provenientes de animais C57Bl/6, mas não em CMLV provenientes de animais deficientes de NLRP3. Esta ativação foi associada ao aumento de EROs e influxo de cálcio. Essa mesma ativação também foi observada em células endoteliais. DNA mitocondrial de camundongos diabéticos também reduziu a dilatação dependente do endotélio em artérias mesentéricas, o que foi associado à geração de EROs e ativação do inflamassoma NLRP3. Pacientes diabéticos apresentaram aumento do DNA mitocondrial circulante e ativação de caspase-1 e IL-1? no soro. Os resultados demonstram que o DNA mitocondrial pancreático de animais diabéticos promove ativação, em CMLV e células endoteliais, do inflamassoma NLRP3 através do aumento no influxo de cálcio e da geração de EROs, contribuindo para o processo de disfunção endotelial. A deficiência de NLRP3 protege os animais diabéticos contra os danos vasculares inflamatórios e disfunção endotelial. / Diabetes mellitus (DM) is associated with several micro and macrovascular complications directly related to cardiovascular diseases. Prolonged exposure to hyperglycemia and insulin resistance are considered the main factors involved in these complications, which are exacerbated by endothelial dysfunction. Inflammatory mediators potentially contribute to the development of endothelial dysfunction by the generation of reactive oxygen species (ROS), which, in turn, stimulate the transcription of pro-inflammatory factors. Specific receptors such as NLRs (NOD-like receptors) contribute to the onset of inflammatory processes by the activation of a multiprotein complex called inflammasome. The NLRP3 inflammasome regulates the activation of caspase-1 and the proteolytic processing of pro-IL-1? and pro-IL-18 precursors into mature cytokines. Several mediators, such as ROS and mitochondrial DNA activate the NLRP3 inflammasome. Considering that it is not clear whether NLRP3 and mitochondrial DNA contribute to diabetes-associated endothelial dysfunction, we hypothesized that the genetic deficiency of the NLRP3 confers resistance to vascular inflammatory processes in animals with type 1 diabetes (T1D) and that mitochondrial DNA contributes to vascular activation of NLRP3 inflammasome and endothelial dysfunction. C57B1/6 and NLRP3 knockout mice were treated with vehicle or streptozotocin to induce T1D. Functional vascular parameters were determined in resistance mesenteric arteries. Cultured vascular smooth muscle cells (VSMC) and endothelial cells were used to determine NLRP3 inflammasome activation by mitochondrial DNA. ROS generation was evaluated by dihydroethidium fluorescence and by chemiluminescence for lucigenin. Caspase-1 and IL-1? activation was evaluated by western blot. Calcium influx was determined by fluorescence and mitochondrial DNA by mRNA expression of mitochondrial components. Diabetes reduced endothelium-dependent vasodilation in C57B1/6, but not in NLRP3 knockout mice. Diabetic mice presented increased vascular NLRP3 receptor expression, increased caspase-1 and IL-1? activation, as well as ROS and hydrogen peroxide generation, events that were mildly observed in NLRP3 knockout mice. There was a reduction in the vascular protein expression of Nox4 (NADPH oxidase 4) as wellas in the gene expression of VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) in NLRP3 knockout animals. There was an increase in cytosolic mitochondrial DNA release in pancreas from diabetic animals. Mitochondrial DNA from the pancreas of diabetic mice induced NLRP3 inflammasome activation in VSMC from C57B1/6 mice, but not in VSMC from NLRP3 knockout mice. This activation was associated with increased levels of ROS and calcium influx and was also detected in endothelial cells. Mitochondrial DNA from diabetic mice also decreased endothelium-dependent dilation in mesenteric arteries, which was associated with ROS generation and NLRP3 inflammasome activation. Diabetic patients exhibited increased serum mitochondrial DNA and caspase-1 and IL-1? activation. The results demonstrate that pancreatic mitochondrial DNA from diabetic mice activates the NLRP3 inflammasome in VSMC and endothelial cells by increasing calcium influx and ROS generation, contributing to endothelial dysfunction. NLRP3 deficiency prevents diabetes-related vascular inflammatory damage and endothelial dysfunction.
107

Papel do inflamassoma NLRP3 nas alterações vasculares promovidas pelo diabetes tipo 1 em modelo induzido por estreptozotocina / Role of the NLRP3 inflammasome in the vascular alterations induced by type 1 diabetes in a streptozotocin-induced model

Camila André Pereira 10 August 2018 (has links)
O diabetes mellitus (DM) está associado a diversas complicações micro e macrovasculares diretamente relacionadas a doenças cardiovasculares. A prolongada exposição à hiperglicemia e a resistência a insulina são considerados os principais fatores envolvidos nestas complicações, as quais são exacerbadas pela disfunção endotelial. Mediadores inflamatórios contribuem potencialmente para o desenvolvimento de disfunção endotelial pela geração de espécies reativas de oxigênio (EROs) que, por sua vez, estimulam a transcrição de fatores pró- inflamatórios. Receptores específicos, como os NLRs (NOD-like receptors, receptores do tipo NOD) contribuem para instalação de processo inflamatório pela ativação do complexo inflamassoma. Este regula a ativação da caspase-1 e o processamento proteolítico dos precursores pró-IL-1? e pró-IL-18 nas citocinas maduras. Diversos mediadores podem ativar o inflamassoma NLRP3 como, por exemplo, EROs e DNA mitocondrial. Pouco é conhecido sobre o envolvimento de receptores NLRP3 e DNA mitocondrial na disfunção endotelial associada ao diabetes. Testamos a hipótese que a deficiência genética do receptor NLRP3 confere resistência à ativação de processo inflamatório na vasculatura de animais com diabetes tipo 1 (DM1) e, ainda, que DNA mitocondrial contribui para a ativação vascular do inflamassoma NLRP3 e para disfunção endotelial. Foram utilizados camundongos C57Bl/6 e deficientes para NLRP3, os quais foram tratados com veículo ou submetidos a protocolo para indução de DM1 com estreptozotocina. Parâmetros vasculares funcionais foram determinados em artérias mesentéricas de resistência. Células de músculo liso vascular (CMLV) e endoteliais foram utilizadas para avaliação da ativação do inflamassoma NLRP3 por DNA mitocondrial. A geração de EROs foi avaliada pela fluorescência para o dihidroetídio e pela quimiluminescência para lucigenina. A ativação de caspase-1 e IL-1? foi avaliada por western blot e o influxo de cálcio, por fluorescência. DNA mitocondrial foi avaliado pela expressão gênica de componentes da mitocôndria. O diabetes reduziu a vasodilatação dependente de endotélio, o que não ocorreu em artérias de animais deficientes de NLRP3. Animais diabéticos apresentaram aumento da expressão vascular do receptor NLRP3, da ativação de caspase-1 eIL-1? e da geração de EROs e peróxido de hidrogênio no leito mesentérico, eventos que ocorreram em menor intensidade em camundongos deficientes de NLRP3. Houve redução na expressão proteica vascular de Nox4 (NADPH oxidase 4), bem como na expressão gênica da molécula de adesão celular vascular-1 (VCAM-1, vascular cell adhesion molecule-1) e molécula de adesão intercelular-1 (ICAM-1, intercellular adhesion molecule-1) em animais deficientes de NLRP3. Houve aumento da liberação de DNA mitocondrial citosólico no pâncreas de animais diabéticos. A incubação com o DNA mitocondrial extraído do pâncreas de animais diabéticos promoveu ativação do inflamassoma em CMLV provenientes de animais C57Bl/6, mas não em CMLV provenientes de animais deficientes de NLRP3. Esta ativação foi associada ao aumento de EROs e influxo de cálcio. Essa mesma ativação também foi observada em células endoteliais. DNA mitocondrial de camundongos diabéticos também reduziu a dilatação dependente do endotélio em artérias mesentéricas, o que foi associado à geração de EROs e ativação do inflamassoma NLRP3. Pacientes diabéticos apresentaram aumento do DNA mitocondrial circulante e ativação de caspase-1 e IL-1? no soro. Os resultados demonstram que o DNA mitocondrial pancreático de animais diabéticos promove ativação, em CMLV e células endoteliais, do inflamassoma NLRP3 através do aumento no influxo de cálcio e da geração de EROs, contribuindo para o processo de disfunção endotelial. A deficiência de NLRP3 protege os animais diabéticos contra os danos vasculares inflamatórios e disfunção endotelial. / Diabetes mellitus (DM) is associated with several micro and macrovascular complications directly related to cardiovascular diseases. Prolonged exposure to hyperglycemia and insulin resistance are considered the main factors involved in these complications, which are exacerbated by endothelial dysfunction. Inflammatory mediators potentially contribute to the development of endothelial dysfunction by the generation of reactive oxygen species (ROS), which, in turn, stimulate the transcription of pro-inflammatory factors. Specific receptors such as NLRs (NOD-like receptors) contribute to the onset of inflammatory processes by the activation of a multiprotein complex called inflammasome. The NLRP3 inflammasome regulates the activation of caspase-1 and the proteolytic processing of pro-IL-1? and pro-IL-18 precursors into mature cytokines. Several mediators, such as ROS and mitochondrial DNA activate the NLRP3 inflammasome. Considering that it is not clear whether NLRP3 and mitochondrial DNA contribute to diabetes-associated endothelial dysfunction, we hypothesized that the genetic deficiency of the NLRP3 confers resistance to vascular inflammatory processes in animals with type 1 diabetes (T1D) and that mitochondrial DNA contributes to vascular activation of NLRP3 inflammasome and endothelial dysfunction. C57B1/6 and NLRP3 knockout mice were treated with vehicle or streptozotocin to induce T1D. Functional vascular parameters were determined in resistance mesenteric arteries. Cultured vascular smooth muscle cells (VSMC) and endothelial cells were used to determine NLRP3 inflammasome activation by mitochondrial DNA. ROS generation was evaluated by dihydroethidium fluorescence and by chemiluminescence for lucigenin. Caspase-1 and IL-1? activation was evaluated by western blot. Calcium influx was determined by fluorescence and mitochondrial DNA by mRNA expression of mitochondrial components. Diabetes reduced endothelium-dependent vasodilation in C57B1/6, but not in NLRP3 knockout mice. Diabetic mice presented increased vascular NLRP3 receptor expression, increased caspase-1 and IL-1? activation, as well as ROS and hydrogen peroxide generation, events that were mildly observed in NLRP3 knockout mice. There was a reduction in the vascular protein expression of Nox4 (NADPH oxidase 4) as wellas in the gene expression of VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) in NLRP3 knockout animals. There was an increase in cytosolic mitochondrial DNA release in pancreas from diabetic animals. Mitochondrial DNA from the pancreas of diabetic mice induced NLRP3 inflammasome activation in VSMC from C57B1/6 mice, but not in VSMC from NLRP3 knockout mice. This activation was associated with increased levels of ROS and calcium influx and was also detected in endothelial cells. Mitochondrial DNA from diabetic mice also decreased endothelium-dependent dilation in mesenteric arteries, which was associated with ROS generation and NLRP3 inflammasome activation. Diabetic patients exhibited increased serum mitochondrial DNA and caspase-1 and IL-1? activation. The results demonstrate that pancreatic mitochondrial DNA from diabetic mice activates the NLRP3 inflammasome in VSMC and endothelial cells by increasing calcium influx and ROS generation, contributing to endothelial dysfunction. NLRP3 deficiency prevents diabetes-related vascular inflammatory damage and endothelial dysfunction.
108

Papel dos inflamassomas na ativação de células dendríticas e na modulação da resposta imune adaptativa. / Role of inflammasome activation in the maturation of dendritic cells and in the development of adaptive imune response.

Thaís Boccia da Costa 07 August 2014 (has links)
O reconhecimento da flagelina pelos NLRs Naip5 e NLRC4 leva à formação do complexo multiproteico denominado inflamassoma que culmina na ativação da caspase-1, com consequente clivagem da forma inativa das citocinas pró-inflamatórias IL-1b e IL-18 e morte da célula infectada. Neste trabalho pudemos observar que in vitro, a maturação de BMDCs com a estimulação com flagelina citosólica, inserida em vesículas lipídicas que permitem a transfecção da flagelina para o citosol, foi independente da ativação de NLRC4, caspase-1 e TLR5, mas somente de MyD88. Já a ativação de linfócitos T por estas BMDCs ativadas por flagelina citosólica é dependente de caspase-1 e MyD88. A neutralização da citocina IL-1a, levou à inibição da ativação de linfócitos T, indicando a contribuição desta para a montagem de resposta imune. A neutralização de IL-1a também levou a uma redução na produção de IL-12, que seria a citocina responsável pela polarização dos linfócitos para Th1. A imunização com flagelina leva ao desenvolvimento de imunidade protetora contra o desafio com S. typhimurium, igualmente dependente de caspase-1 e MyD88. Podemos dizer que a flagelina induz resposta imune tanto in vivo quanto in vitro e que, em ambos os casos, há a participação das moléculas caspase-1 e MyD88. / TLR5 activates inflammatory genes through MyD88 pathway whereas NLRC4 and NAIP5 assemble multiprotein complexes called inflammasomes, leading to caspase-1 activation and secretion of proinflammatory cytokines IL-1 and IL-18. Cytosolic flagellin (FLA-BSDot) induced upregulation of costimulatory molecules independent on TLR5, NLRC4 and Caspase-1, but dependent on MyD88. In addition, FLA-BSDot-stimulated OVA-pulsed BMDCs induced proliferation and production of IFN by OT-II splenocytes, dependent on caspase-1 and MyD88. FLA-BSDot stimulation leads to the secretion of IL-1 and IL-1. Neutralization of IL-1 inhibited BMDCs maturation in response to FLA-BSDot and led to decreased IFN production by OT-II splenocytes. Searching for the effector mechanism by which IL-1 induces Th1 polarization in response to FLA-BSDot, we observed a significant reduction in IL-12 production when IL-1 was neutralized. Also, we could see that adaptive immune responses induced by flagellin in vivo was protective against S.typhimurium lethal challenge, showing again a role for caspase-1 and MyD88. From these data we can infer that caspase-1 and MyD88 are both involved in the adaptive response induced by flagelin both in vitro and in vivo.
109

Papel dos inflamassomas na ativação de células dendríticas e na modulação da resposta imune adaptativa. / Role of inflammasome activation in the maturation of dendritic cells and in the development of adaptive imune response.

Costa, Thaís Boccia da 07 August 2014 (has links)
O reconhecimento da flagelina pelos NLRs Naip5 e NLRC4 leva à formação do complexo multiproteico denominado inflamassoma que culmina na ativação da caspase-1, com consequente clivagem da forma inativa das citocinas pró-inflamatórias IL-1b e IL-18 e morte da célula infectada. Neste trabalho pudemos observar que in vitro, a maturação de BMDCs com a estimulação com flagelina citosólica, inserida em vesículas lipídicas que permitem a transfecção da flagelina para o citosol, foi independente da ativação de NLRC4, caspase-1 e TLR5, mas somente de MyD88. Já a ativação de linfócitos T por estas BMDCs ativadas por flagelina citosólica é dependente de caspase-1 e MyD88. A neutralização da citocina IL-1a, levou à inibição da ativação de linfócitos T, indicando a contribuição desta para a montagem de resposta imune. A neutralização de IL-1a também levou a uma redução na produção de IL-12, que seria a citocina responsável pela polarização dos linfócitos para Th1. A imunização com flagelina leva ao desenvolvimento de imunidade protetora contra o desafio com S. typhimurium, igualmente dependente de caspase-1 e MyD88. Podemos dizer que a flagelina induz resposta imune tanto in vivo quanto in vitro e que, em ambos os casos, há a participação das moléculas caspase-1 e MyD88. / TLR5 activates inflammatory genes through MyD88 pathway whereas NLRC4 and NAIP5 assemble multiprotein complexes called inflammasomes, leading to caspase-1 activation and secretion of proinflammatory cytokines IL-1 and IL-18. Cytosolic flagellin (FLA-BSDot) induced upregulation of costimulatory molecules independent on TLR5, NLRC4 and Caspase-1, but dependent on MyD88. In addition, FLA-BSDot-stimulated OVA-pulsed BMDCs induced proliferation and production of IFN by OT-II splenocytes, dependent on caspase-1 and MyD88. FLA-BSDot stimulation leads to the secretion of IL-1 and IL-1. Neutralization of IL-1 inhibited BMDCs maturation in response to FLA-BSDot and led to decreased IFN production by OT-II splenocytes. Searching for the effector mechanism by which IL-1 induces Th1 polarization in response to FLA-BSDot, we observed a significant reduction in IL-12 production when IL-1 was neutralized. Also, we could see that adaptive immune responses induced by flagellin in vivo was protective against S.typhimurium lethal challenge, showing again a role for caspase-1 and MyD88. From these data we can infer that caspase-1 and MyD88 are both involved in the adaptive response induced by flagelin both in vitro and in vivo.
110

Inflammation du tissu adipeux chez le sujet obèse et au cours de la perte de poids : nouveau dialogue paracrine entre macrophages et lymphocytes

Dalmas, Elise 05 July 2012 (has links) (PDF)
L'obésité est un état inflammatoire chronique dit de " bas grade ", associé à l'augmentation de facteurs pro-inflammatoires dans la circulation et le tissu adipeux. Chez les sujets obèses, nous montrons qu'une série de facteurs inflammatoires sériques évoluent selon une régulation bi-phasique au cours de la perte de poids induite par chirurgie bariatrique, avec une diminution drastique à 3 mois suivie d'un rebond et d'une stabilisation à 1 an. Le statut nutritionnel des patients est un déterminant majeur de ce profile inattendu. Chez ces sujets, nous mettons en évidence un enrichissement en monocytes circulants " non classiques " CD14dimCD16+, dont l'abondance diminue après perte de poids. La relevance clinique de ces observations reste à explorer. Le tissu adipeux est un site d'accumulation de cellules immunitaires dans l'obésité, mais les voies de communication entre ces cellules sont mal connues. Nous montrons que les macrophages du tissu adipeux sécrètent de l'IL-1β en réponse à l'activation de l'inflammasome NLRP3. Ce processus est augmenté chez les patients obèses diabétiques (T2D) et atténué après perte de poids. Par ailleurs, nous montrons que le tissu adipeux des patients T2D est enrichi en une population de lymphocytes produisant à la fois de l'IL-17+ et de l'IFN-β+. Dans un système de co-culture, l'IL-1β produite par les macrophages du tissu adipeux stimulent la production d'IL17 par les lymphocytes, et réciproquement. Ces résultats suggèrent que IL-1β et IL-17 sont deux cytokines clés à la base d'un dialogue paracrine et pro-inflammatoire entre macrophages et lymphocytes du tissu adipeux, spécifiquement augmenté chez les patients obèses diabétiques.

Page generated in 0.0327 seconds